These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 1569235)

  • 81. Noninvasive assessment of the haemodynamic effects of nicardipine in normotensive subjects.
    Campbell BC; Kelman AW; Hillis WS
    Br J Clin Pharmacol; 1985; 20 Suppl 1(Suppl 1):55S-61S. PubMed ID: 4027151
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Pharmacokinetics and pharmacodynamics of nifedipine in children with bronchopulmonary dysplasia and pulmonary hypertension.
    Johnson CE; Beekman RH; Kostyshak DA; Nguyen T; Oh DM; Amidon GL
    Pediatr Res; 1991 May; 29(5):500-3. PubMed ID: 1896255
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Comparative actions of dihydropyridine slow channel calcium blocking agents in conscious dogs: systemic and coronary hemodynamics with and without combined beta adrenergic blockade.
    Warltier DC; Zyvoloski MG; Gross GJ; Brooks HL
    J Pharmacol Exp Ther; 1984 Aug; 230(2):367-75. PubMed ID: 6146711
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Acute haemodynamic effects of a new calcium antagonist, nicardipine, in man. A comparison with nifedipine.
    Iliopoulou A; Turner P; Warrington SJ
    Br J Clin Pharmacol; 1983 Jan; 15(1):59-65. PubMed ID: 6849746
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Hemodynamic effects of acute administration of slow-release nifedipine in elderly patients with systolic hypertension.
    Strano A; Novo S; Modica R; Nardi E; Donia G
    Am J Nephrol; 1986; 6 Suppl 1():91-4. PubMed ID: 3826158
    [No Abstract]   [Full Text] [Related]  

  • 86. Comparative study on acute antihypertensive effects and pharmacokinetics of nisoldipine, nifedipine, nimodipine and nicardipine administered orally to conscious renal hypertensive dogs.
    Takata Y; Kato H
    Arzneimittelforschung; 1986 Oct; 36(10):1464-71. PubMed ID: 3814208
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Influence of atenolol and nifedipine on digoxin-induced inotropism in humans.
    Hansen PB; Buch J; Rasmussen OO; Waldorff S; Steiness E
    Br J Clin Pharmacol; 1984 Dec; 18(6):817-22. PubMed ID: 6529522
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Rectal administration of nifedipine: haemodynamic effects and pharmacokinetics in hypertensives.
    Kurosawa S; Kurosawa N; Owada E; Matsuhashi N; Ito K
    J Int Med Res; 1987; 15(3):121-7. PubMed ID: 3609449
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Effect of cimetidine or ranitidine administration on nifedipine pharmacokinetics and pharmacodynamics.
    Schwartz JB; Upton RA; Lin ET; Williams RL; Benet LZ
    Clin Pharmacol Ther; 1988 Jun; 43(6):673-80. PubMed ID: 3378388
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Effects of turmeric extract on the pharmacokinetics of nifedipine after a single oral administration in healthy volunteers.
    Ikehata M; Ohnishi N; Egami S; Kishi H; Shin Y; Takara K; Tsuchishita Y; Tokuda N; Hori S; Yatani Y; Fujimura Y; Kusumoto M; Tatami R; Yoshioka M; Kuroda K; Yamada S; Yokoyama T
    J Diet Suppl; 2008; 5(4):401-10. PubMed ID: 22436099
    [TBL] [Abstract][Full Text] [Related]  

  • 91. The influence of nimodipine on hemodynamic parameters and peak and trough plasma concentrations of nifedipine chronically administered to elderly hypertensive patients.
    Breuel HP; Mück W; Heine PR; Schmage N; Niklaus H; Kuhlmann J
    Int J Clin Pharmacol Ther; 1995 Feb; 33(2):109-13. PubMed ID: 7757309
    [TBL] [Abstract][Full Text] [Related]  

  • 92. [Absence of polymorphism in individual response to the dihydropyridines nifedipine and (+/-)-nicardipine].
    Porchet HC; Benveniste C; Adler D; Dayer P
    Schweiz Med Wochenschr; 1988 Dec; 118(50):1918-20. PubMed ID: 3222686
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Influence of simvastatin at high dose and nifedipine on hemodynamic parameters in rabbits.
    Jasińska M; Owczarek J; Orszulak-Michalak D
    Pharmacol Rep; 2006; 58(1):48-59. PubMed ID: 16531630
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Pharmacokinetics of nifedipine slow release tablet in Mexican subjects: further evidence for an oxidation polymorphism.
    Hoyo-Vadillo C; Castañeda-Hernández G; Herrera JE; Vidal-Gárate J; Moreno-Ramos A; Chávez F; Hong E
    J Clin Pharmacol; 1989 Sep; 29(9):816-20. PubMed ID: 2808746
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Pharmacokinetics of nifedipine after oral administration in chronic liver disease.
    Ene MD; Roberts CJ
    J Clin Pharmacol; 1987 Dec; 27(12):1001-4. PubMed ID: 3437063
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Pharmacokinetics of oral nifedipine in different populations.
    Castañeda-Hernández G; Hoyo-Vadillo C; Palma-Aguirre JA; Flores-Murrieta FJ
    J Clin Pharmacol; 1993 Feb; 33(2):140-5. PubMed ID: 8440762
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Aspects of the clinical pharmacology of nifedipine, a dihydropyridine calcium-entry antagonist.
    Hamann SR; Piascik MT; McAllister RG
    Biopharm Drug Dispos; 1986; 7(1):1-10. PubMed ID: 3513860
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Intraindividual variability of fibrinogen levels and cardiovascular risk profile.
    Rosenson RS; Tangney CC; Hafner JM
    Arterioscler Thromb; 1994 Dec; 14(12):1928-32. PubMed ID: 7981181
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Individual features of circulatory power spectra in man.
    Honzíková N; Penáz J; Fiser B
    Eur J Appl Physiol Occup Physiol; 1990; 59(6):430-4. PubMed ID: 2303048
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Nifedipine: variability in its kinetics and metabolism in man.
    Breimer DD; Schellens JH; Soons PA
    Pharmacol Ther; 1989; 44(3):445-54. PubMed ID: 2519350
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.